# Xpede Clinical Study

> **NCT03730207** · NA · COMPLETED · sponsor: **Medtronic Spinal and Biologics** · enrollment: 180 (actual)

## Conditions studied

- Pathological Fracture of Vertebra Due to Secondary Osteoporosis (Disorder)
- Pathological Fracture of Vertebra Due to Neoplastic Disease (Disorder)

## Interventions

- **DEVICE:** Xpede™ Bone Cement
- **DEVICE:** Mendec Spine Bone Cement

## Key facts

- **NCT ID:** NCT03730207
- **Lead sponsor:** Medtronic Spinal and Biologics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-18
- **Primary completion:** 2021-10-14
- **Final completion:** 2021-10-14
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2023-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03730207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03730207, "Xpede Clinical Study". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT03730207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*